Cargando…
PDGF is Required for Remyelination-Promoting IgM Stimulation of Oligodendrocyte Progenitor Cell Proliferation
BACKGROUND: Promotion of remyelination is a major goal in treating demyelinating diseases such as multiple sclerosis (MS). The recombinant human monoclonal IgM, rHIgM22, targets myelin and oligodendrocytes (OLs) and promotes remyelination in animal models of MS. It is unclear whether rHIgM22-mediate...
Autores principales: | Watzlawik, Jens O., Warrington, Arthur E., Rodriguez, Moses |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562326/ https://www.ncbi.nlm.nih.gov/pubmed/23383310 http://dx.doi.org/10.1371/journal.pone.0055149 |
Ejemplares similares
-
Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease
por: Wootla, Bharath, et al.
Publicado: (2015) -
A monoclonal natural human IgM protects axons in the absence of remyelination
por: Wootla, Bharath, et al.
Publicado: (2016) -
A patterned recombinant human IgM guides neurite outgrowth of CNS neurons
por: Xu, Xiaohua, et al.
Publicado: (2013) -
Remyelination-Promoting Human IgMs: Developing a Therapeutic Reagent for Demyelinating Disease
por: Warrington, A. E., et al.
Publicado: (2008) -
Pericytes Stimulate Oligodendrocyte Progenitor Cell Differentiation during CNS Remyelination
por: De La Fuente, Alerie Guzman, et al.
Publicado: (2017)